Small changes in cancer mortality. Time for a bigger prevention drive?
Lenner, P.; Jonsson, H.; Gardfjell, O.
Lakartidningen 87(35): 2658-2660
1990
ISSN/ISBN: 0023-7205 PMID: 2214971 Document Number: 356418
Document emailed within 1 workday
Related Documents
Meara, E.R.; Richards, S.; Cutler, D.M. 2008: The gap gets bigger: changes in mortality and life expectancy, by education, 1981-2000 Health Affairs 27(2): 350-360Robeznieks, A. 2007: Big guys getting bigger: study. Small doc practices still lead, but numbers shrinking Modern Healthcare 37(33): 33
Benko, L.B. 2003: Going for the green. as higher premiums and stable medical costs fuel health plans' profits, providers say time is right to win bigger reimbursement Modern Healthcare 33(33): 6-7; 14-15, 1
Nowara, E.; Suwiński, R.ł 2005: Time factor in radiotherapy and chemotherapy for small cell lung cancer Pneumonologia i Alergologia Polska 73(1): 23-31
Adami, H.O. 1984: Breast cancer incidence and mortality. Aspects on aetiology, time trends and curability Acta Chirurgica Scandinavica. Supplementum 519: 9-14
Wiatr, E.; Bestry, I.; Zych, J.; Grymiński, J. 1993: Stage and regression time of radiological changes in patients treated for small cell lung cancer Pneumonologia i Alergologia Polska 61(1-2): 46-51
Sahin, C.; Omar, M.; Tunca, H.; Kalemci, S.; Ozseker, B.; Akbaba, G.; Tanriverdi, O. 2015: Weight loss at the time of diagnosis is not associated with prognosis in patients with advanced-stage non-small cell lung cancer Journal of BUON: Official Journal of the Balkan Union of Oncology 20(6): 1576-1584
Iyoda, K.; Okazaki, T.; Ogawa, K.; Murao, S. 2006: Driving license for persons with epilepsy--to drive or not to drive-- No to Hattatsu 38(5): 375-376
Fujita, A.; Igami, Y.; Takabatake, H.; Tagaki, S.; Yamamoto, R.; Sekine, K. 1999: Period of time patients with advanced non-small cell lung cancer could remain at home during CIC--therapy (cisplatin + ifosfamide + CPT-11) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(6): 805-811
Seffner, F.; Garcia, J.; Muñoz-Laboy, M.; Parker, R. 2011: A time for dogma, a time for the Bible, a time for condoms: building a Catholic theology of prevention in the face of public health policies at Casa Fonte Colombo in Porto Alegre, Brazil Global Public Health 6 Suppl. 2: S271-S283
King, H.; Locke, F.B. 1988: The National Mortality Survey of China: implications for cancer control and prevention Cancer Detection and Prevention 13(3-4): 157-166
Sakamoto, M.; Mikasa, K.; Majima, T.; Konishi, M.; Maeda, K.; Yoshimoto, E.; Murakawa, K.; Takahashi, K.; Kita, E.; Narita, N. 2000: Usefulness of clarithromycin in paitents with unresectable non-small-cell lung cancer--clinical evaluation of those who survived for a long time and those succumbed in a short period Japanese Journal of Antibiotics 53 Suppl A: 56-59
Rizou, T.; Perlikos, F.; Lagiou, M.; Karaglani, M.; Nikolopoulos, S.; Toumpoulis, I.; Kroupis, C. 2018: Development of novel real-time RT-qPCR methodologies for quantification of the COL11A1 mRNA general and C transcripts and evaluation in non-small cell lung cancer specimens Journal of BUON: Official Journal of the Balkan Union of Oncology 23(6): 1699-1710
Saphir, A. 1999: At the center of cancer care. For-profit outpatient centers playing bigger role in treatment, clinical trials Modern Healthcare 29(22): 28-30
Sharp, L.; Brewster, D. 1999: The epidemiology of lung cancer in Scotland: a review of trends in incidence, survival and mortality and prospects for prevention Health Bulletin 57(5): 318-331
Huggan, P.J.; Foo, R.Min.; Olszyna, D.; Chew, N.S.; Smitasen, N.; Mukhopadhyay, A.; Archuleta, S. 2012: Presentation and outcome amongst older Singaporeans living with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS): does age alone drive excess mortality? Annals of the Academy of Medicine Singapore 41(12): 581-586
Mathers, C.D.; Shibuya, K.; Boschi-Pinto, C.; Lopez, A.D.; Murray, C.J.L. 2002: Global and regional estimates of cancer mortality and incidence by site: I. Application of regional cancer survival model to estimate cancer mortality distribution by site Bmc Cancer 2: 36
Huchko, M.J.; Maloba, M.; Nakalembe, M.; Cohen, C.R. 2015: The time has come to make cervical cancer prevention an essential part of comprehensive sexual and reproductive health services for HIV-positive women in low-income countries Journal of the International Aids Society 18(Suppl. 5): 20282
Neill, H.B.; Miller, A.A.; Clamon, G.H.; Perry, M.C.; Crawford, J.; Green, M.R. 1997: A phase Ii study evaluating the efficacy of carboplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in patients with stage IIIB and IV non-small cell lung cancer and extensive small cell lung cancer Seminars in Oncology 24(4 Suppl 12: S12
Shin, H-Rim.; Park, S.; Hwang, S-Young.; Kim, J-Eun.; Jung, K-Won.; Won, Y-Joo.; Hwang, S-Sik.; Yim, S-Hee.; Choi, K.Son.; Park, E-Cheol.; Park, S-Yoon.; Kim, J.Weon.; Lee, H-Pyo. 2008: Trends in cervical cancer mortality in Korea 1993-2002: corrected mortality using national death certification data and national cancer incidence data International journal of cancer 122(2): 393-397